Drugs for Neglected Diseases initiative (DNDi)
@dndi.org
6.8K followers 590 following 300 posts
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.
Posts Media Videos Starter Packs
dndi.org
We're heading to Berlin for #WHS2025!
Join our R&D Director Laurent Fraisse for the session: The Future of Combatting Neglected Tropical Diseases
📅 Monday, 13 Oct | 🕚 11:00–12:30 CEST
🔗 More info: dndi.org/events/2025/...
🎥 Watch live: youtube.com/watch?v=lCvS...
dndi.org
We will join partners at the 78th #WHOSEARO Regional Committee in Colombo on October 14 to mark 20 years of the Regional Kala-azar Elimination Initiative and to advance collaboration for multi-disease elimination across South Asia.

👉More info: bit.ly/4ourjBp
dndi.org
At DNDi, we are actively engaged in this research space, including through our drug discovery and drug repurposing efforts, to identify and deliver new treatments for the most neglected patients. (4/4)
dndi.org
Their work paves the way for the development of innovative treatments not only for cancer and autoimmune diseases, but also for neglected infectious diseases such as dengue, Chagas and cutaneous leishmaniasis—diseases that are largely neglected by market-driven R&D. (3/4)
dndi.org
Their groundbreaking discoveries on peripheral immune tolerance helped us understand how the immune system dysregulation is closely linked to the development of numerous diseases. (2/4)
dndi.org
🎬 Meet Henry — The Boy Who Beat The Sandfly.

A powerful story of resilience, hope, and the urgent need for better treatments for children with #VisceralLeishmaniasis.

📽️ Trailer out now. Full film coming soon!

#ZeroLeish #NNN2025 #GlobalHealth #KalaAzar
Reposted by Drugs for Neglected Diseases initiative (DNDi)
dndi.org
Children are too often left out of clinical trials. In Nature, our Head of HIV Justine Odionyi calls for drug development on neglected diseases to include children from the start. Read the piece (EN/FR): @nature.com #BeatNTDs #GlobalHealth www.nature.com/articles/d44...
Drug development for neglected diseases must account for kids
Including children in trials, shaping regulation locally, could deliver safer, more effective therapies in Africa.
www.nature.com
dndi.org
Skin diseases can block progress toward #UHC. Strengthening primary care for skin conditions means better access for all, ensuring no one is left behind.

'There is potential for inclusion of new therapies in the @who.int essential medicines list.' says @bornanyaoke.bsky.social

#NNN2025
dndi.org
Chrispin Owaga, new #NNN2025 chair for the #schistosomiasis working group, calls for a strategy shift: with global funding landscapes changing and drug donation resources dwindling, innovation in diagnostics, treatments & vaccines is more critical than ever. #beatNTDs
dndi.org
The way forward:
💡 Stronger coordination
💡 Cross-border collaboration
💡 Investment in research & access
💡 Sustained advocacy

Together, we’re building momentum toward #ZeroLeish and a future where no patient is left behind.
dndi.org
This week at #NNN2025, together with The END Fund, we hosted the Eastern Africa #VisceralLeishmaniasis annual review meeting.

Over 3 days, partners shared progress, explored innovations, and addressed challenges—from surveillance gaps to climate-driven outbreaks.
Reposted by Drugs for Neglected Diseases initiative (DNDi)
thirugeneva.bsky.social
Michelle Childs (DNDi): Disclosing R&D costs is an accountability tool.
Reposted by Drugs for Neglected Diseases initiative (DNDi)
eadirectordndi.bsky.social
The annual programme review meeting for visceral ##leishmaniasis in Eastern Africa has started in Kampala, Uganda with @dndi.org and The END Fund.

Looking forward to fruitful deliberations on addressing challenges and closing the gaps through partnerships to achieve elimination. #ZeroLeish
dndi.org
The #NNN2025 has begun! It kicked off with a powerful call from communities with lived experience: we must be participants, not just beneficiaries, in decision-making, policy change, and project design. Looking forward to 3 days of vital conversations on neglected diseases.
Reposted by Drugs for Neglected Diseases initiative (DNDi)
dndi.org
'This declaration is not made lightly but is driven by the urgent need to protect lives and mobilize all stakeholders toward an effective, coordinated response.'

VL is one of the deadliest parasitic killers after malaria & we need better treatments to control the disease. (2/2)
Reposted by Drugs for Neglected Diseases initiative (DNDi)
ndm.ox.ac.uk
Scientists at @cmd.ox.ac.uk have helped develop a crowdsourced, open-science #coronavirus antiviral. Nominated as a broad-spectrum pre-clinical drug candidate by @dndi.org, it's designed to be a globally accessible treatment for future pandemics 💊🦠

Learn more 👉 buff.ly/35Wdlbn
dndi.org
Last week, we had an engaging media cafe with #science journalists from across East Africa on how to report on #ClinicalTrials.
Thank you to our panelists Dr Bernhards Ogutu, Dr @bornanyaoke.bsky.social, Linet Otieno, Mercy Mumo and to Talk Africa for organizing and moderating the session.